Sotera Health Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	117.8	77.95	44.4	51.38	-233.57	117.12
Depreciation & Amortization	126.72	136.71	163.64	157.93	145.55	150.9
Stock-Based Compensation	38.03	30.88	36.78	32.24	21.21	13.87
Other Adjustments	26.06	13.62	21.99	14.01	-64.47	12.24
Change in Receivables	-5.59	7.15	2.22	-21.72	-12.56	-15.51
Changes in Inventories	5.37	-2.38	-4.75	-9.97	14.44	-20.25
Changes in Accounts Payable	-3.67	5.19	-6.64	-5.33	1.11	19.76
Changes in Accrued Expenses	1.25	1.94	7.11	3.5	20.6	1.6
Changes in Income Taxes Payable	2.69	-5.46	1.47	0.92	-12.33	10.1
Changes in Other Operating Activities	-43.95	21.61	-42.04	-370.68	397.98	-8.3
Operating Cash Flow	261.11	287.2	224.16	-147.73	277.96	281.55
Operating Cash Flow Growth	-3.29%	28.12%	-	-	-1.27%	133.48%
Capital Expenditures	-164.27	-138.02	-179.07	-214.98	-182.38	-102.16
Payments for Business Acquisitions	-	-	-	-	0.45	-56.97
Other Investing Activities	3.88	2.87	0.07	0.07	0.03	-0.7
Investing Cash Flow	-160.39	-135.14	-179	-214.91	-181.9	-159.83
Short-Term Debt Repaid	-	-	-	-200	-	-
Net Short-Term Debt Issued (Repaid)	-	-	-	-200	-	-
Long-Term Debt Issued	-	-	2,259	500	200	-
Long-Term Debt Repaid	-10.89	-86.1	-2,264	-2.5	-	-100
Net Long-Term Debt Issued (Repaid)	-10.89	-86.1	-5.02	497.5	200	-100
Repurchase of Common Stock	-11.77	-6.57	-4.43	-4.09	-0.39	-1.43
Net Common Stock Issued (Repurchased)	-11.77	-6.57	-4.43	-4.09	-0.39	-1.43
Other Financing Activities	-4.59	-7.86	-41.11	-27.45	-1.85	-15.85
Financing Cash Flow	-105.23	-100.53	-50.56	265.96	197.76	-117.29
Effect of Exchange Rate Changes on Cash and Cash Equivalents	14.37	16.07	-17.39	2.04	-4.46	0.04
Net Cash Flow	43.11	67.59	-22.79	-94.64	289.37	4.47
Free Cash Flow	96.84	149.18	45.09	-362.71	95.58	179.38
Free Cash Flow Growth	-35.08%	230.81%	-	-	-46.72%	167.42%
FCF Margin	8.14%	12.82%	4.10%	-34.57%	9.52%	19.26%
Free Cash Flow Per Share	0.34	0.52	0.16	-1.28	0.34	0.64
Levered Free Cash Flow	31.05	11.43	-20.91	-89.74	351.4	68.54
Unlevered Free Cash Flow	143.03	210.9	55.76	-304.54	623.57	222.78

SEC Filings: 10-K · 10-Q